Disclosed are PAP mutants that are less toxic than wild type PAP and that exhibit depurination activity. Also disclosed are transgenic plants that procedure the PAP mutants, and methods for preparing the plants. Further disclosed are bioconjugates containing the PAP mutants, pharmaceutical compositions containing the bioconjugates, and methods of administering the compositions to treat disease.

 
Web www.patentalert.com

< Self-adaptive system for the automatic detection of discomfort and the automatic generation of SCS therapies for chronic pain control

> Genes responsible for vernalization regulation in temperate grasses and uses thereof
~ 00482